Enhancement of silymarin solubility and dissolution by nicotinamide-based solid dispersion employing the kneading method

Main Article Content

Bushra Malik Jassim
Eman B. H. AL-Khedairy

Keywords

pharmaceutical; silymarin solubility; nicotinamide-based

Abstract

Silymarin (SM) is a herbal medicine extracted from the plant Silybum marianum. SM has many potent pharmacological activities among which are antioxidant, anti-inflammatory, and possible wound-healing properties. It belongs to BCS class II thus the drug is practically water insoluble with poor dissolution. In this paper the main aim is to modify solubility and dissolution of SM , one SD preparation method is used which is the Kneading method (Kn). The carrier that has being used is nicotinamide(NA) , Nicotinamide shows promise for the treatment of a wide range of dermatological conditions including autoimmune blistering disorders, acne, rosacea, ageing skin and atopic dermatitis. In particular, recent studies have also shown it to be a potential agent for wound healing, reducing actinic keratoses and preventing skin cancers. Solid dispersion (SD) was characterized for percentage yield, drug content, saturation solubility, and in-vitro dissolution study in comparing to pure drug. Formulation evaluated by Fourier-transform infrared spectroscopy, differential scanning colorimetry, X-ray diffraction.

Abstract 290 | pdf Downloads 118

References

1. Sinha S, Ali M, Baboota S, Ahuja A, Kumar A, Ali J. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech. 2010;11(2):518-527. doi:10.1208/s12249-010-9404-1.
2. Tekade AR, Yadav JN. A Review on Solid Dispersion and Carriers Used Therein for Solubility Enhancement of Poorly Water Soluble Drugs. Adv Pharm Bull. 2020;10(3):359-369. doi:10.34172/apb.2020.044.
3. Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. "Silymarin", a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci. 2011;14(4):308-317.
4. Yousaf AM, Malik UR, Shahzad Y, Mahmood T, Hussain T. Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization. J Pharm Anal. 2019;9(1):34-39. doi:10.1016/j.jpha.2018.09.003.
5. Verma, M Mohan et al. “Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.” Bollettino chimico farmaceutico vol. 142,3 (2003): 119-24.
6. Ghareeb MM, Abdulrasool AA, Hussein AA, Noordin MI. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS PharmSciTech. 2009;10(4):1206-1215. doi:10.1208/s12249-009-9316-0.
7. Hassani, Hiba & Al-khedairy, Eman. (2021). Formulation and In-Vitro Evaluation of Meloxicam Solid Dispersion using Natural Polymers.. Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512). 30. 169-178. 10.31351/vol30iss1pp169-178.
8. Sharma A, Jain CP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res Pharm Sci. 2010;5(1):49-56.
9. Arora SC, Sharma PK, Irchhaiya R, Khatkar A, Singh N, Gagoria J. Development, characterization and solubility study of solid dispersions of Cefuroxime Axetil by the solvent evaporation method. J Adv Pharm Technol Res. 2010;1(3):326-329. doi:10.4103/0110-5558.72427
10. Dalwadi, Dr. Sonali & Soni, Tejal & Thakkar, Vaishali & Tejal, Gandhi. (2010). Silymarin-solid dispersions: Characterization and influence of preparation methods on dissolution. Actapharmaceutica (Zagreb, Croatia). 60. 427-43. 10.2478/v10007-010-0038-3.
11. Song, I.-S.; Nam, S.-J.; Jeon, J.-H.; Park, S.-J.; Choi, M.-K. Enhanced Bioavailability and Efficacy of Silymarin Solid Dispersion in Rats with Acetaminophen-Induced Hepatotoxicity. Pharmaceutics 2021, 13, 628. https://doi.org/10.3390/pharmaceutics13050628
12. Dispersions S. Effect of Hydrophilic Carriers for Solubility and Dissolution Enhancement of Effect of Hydrophilic Carriers for Solubility and Dissolution Enhancement of Sulfamerazine by Solid Dispersions Technique. 2021;(December).
13. Michael E. Aulton KMGT. Aulton-Pharmaceutics-The-Design-and-Manufacture-of-Medicines-5th-Edition. Vol. 5, Aulton’s Pharmaceutics The Design and Manufacture of Medicines. 2018. 933 p.
14. Saiyyad, Irfan & Bhambere, Deepak & Kshirsagar, Sanjay. (2017). Formulation and Optimization of Silymarin Loaded PLGA
Nanoparticle for liver targeting. 10.13140/RG.2.2.35383.16809.
15. Yadav, Dattatraya & Savjani, Jignasa & Savjani, Ketan & Kumar, Aakash & Patel, Snehal. (2022). Pharmaceutical Co-crystal of Antiviral Agent Efavirenz with Nicotinamide for the Enhancement of Solubility, Physicochemical Stability, and Oral Bioavailability. AAPS PharmSciTech. 24. 10.1208/s12249-022-02467-7.
16. Gandey S, Aparna V, Kandarapu R. Preparation and Biological Evaluation of Silybin Liposomes for the Treatment of Liver Disorders. J Pharm Res Int. 2021;(July):186–200.
17. Oryan A, Tabatabaei Naeini A, Moshiri A, Mohammadalipour A, Tabandeh MR. Modulation of cutaneous wound healing by silymarin in rats. J Wound Care. 2012;21(9):457–64.
18. Sharifi R, Pasalar P, Kamalinejad M, Dehpour AR, Tavangar SM, Paknejad M, et al. The effect of silymarin (Silybum marianum) on human skin fibroblasts in an in vitro wound healing model. Pharm Biol. 2013;51(3):298–303.